Cargando…
Impact of dysautonomic symptom burden on the quality of life in Neuromyelitis optica spectrum disorder patients
BACKGROUND: This study aimed to investigate the clinical risk factors of dysautonomic symptom burden in neuromyelitis optica spectrum disorder (NMOSD) and its impact on patients’ quality of life. METHODS: A total of 63 NMOSD patients and healthy controls were enrolled. All participants completed the...
Autores principales: | Yang, Lili, Li, Wenjing, Xie, Yan, Ma, Shuai, Zhou, Xiaobo, Huang, Xinyue, Tan, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026430/ https://www.ncbi.nlm.nih.gov/pubmed/36941592 http://dx.doi.org/10.1186/s12883-023-03162-1 |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis optica spectrum disorder: Patient experience and quality of life
por: Beekman, Janine, et al.
Publicado: (2019) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)